TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | 33 | 21 | -7 | -36 | -20 | -1 |
| P | %wins | 100 | 100 | 100 | 0 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/2/13 15:48 | 12/28/12 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Bent Michael A | CO | O | VPActg. | M.d | 10 | 3.40 | 0 | 3 | 44 | 10 | D | 94 | 21 | -25 | -11 | -2 | -4 | -5 | -3 | 2 | 7 | 4 | 12 | -16 | 8 |
10/1/12 16:12 | 9/27/12 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Bent Michael A | CO | O | VPActg. | M.d | 32 | 7.00 | 0 | 5 | 198 | 7 | D | 106 | 8 | -19 | -19 | 11 | 14 | 1 | 0 | 3 | 5 | -2 | -8 | 1 | -35 |
3/29/12 16:46 | 3/27/12 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Bent Michael A | CO | O | VPActg. | M.d | 26 | 9.90 | 1 | 3 | 90 | 5 | D | 35 | 82 | 34 | 63 | 40 | -6 | -4 | -2 | 1 | 2 | 10 | -2 | -18 | -17 |
2/26/10 15:16 | 2/25/10 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Bent Michael A | CO | O | VPActg. | P | 2 | 0.6996 | 0 | 3 | 7 | 44 | D | -58 | 192 | 59 | 67 | 6 | 9 | 0 | 1 | 3 | 33 | 21 | -7 | -36 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |